Beta-Testing of New HealthTab™ System in First Shoppers Drug Mart® Pharmacy Performs Well, Shows Strong Patient Demand
VANCOUVER, BRITISH COLUMBIA – July 19, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company”; or “AVCR”) announces that patient testing has begun on the first deployment of the new HealthTab™-integrated Afinion 2™ analyzers in the initial Shoppers Drug Mart® pharmacy location as part of its previously announced effort to screen for diabetes and cardiovascular […]
Avricore Health CEO Hosts Investor Call July 6th
VANCOUVER, BRITISH COLUMBIA – June 30, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is hosting the first of a regular series of investor calls hosted by the Company’s CEO and key team members to provide progress updates and take questions. “We have many enthusiastic supporters, and we want to be able […]
First HealthTab™ Testing Success in Shoppers Drug Mart® Pilot Rollout
VANCOUVER, BRITISH COLUMBIA – June 29, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has successfully launched HealthTab™ in the first of 11 Shoppers Drug Mart pilot locations. The rollout is part of its recently announced Master Agreement and Statement of Work. Under the agreement, the initial Ontario locations will […]
Avricore Health Inc To Webcast Live at Life Sciences Investor Forum June 24th
Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) based in Vancouver, Canada focused on networked point-of-care testing in pharmacies technology HealthTab™ today announced that CEO, Hector Bremner will present live at LifeSciencesInvestorForum.com on June 24 th . DATE: Thursday, June 24 th TIME: 11:00am PT / 2:00pm ET LINK: https://bit.ly/3c7Ertp This will be a live, […]
Avricore Health Corporate Update Summer 2021
VANCOUVER, BRITISH COLUMBIA – June 9, 2021) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s successes in 2021, which have included securing significant financing and key commercial agreements, putting it on track for its most successful year to date. “We’ve demonstrated a unique […]
Avricore Health Signs Master Agreement To Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
VANCOUVER, BC – (GLOBE NEWSWIRE) – June 3, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have access to its innovative point-of-care blood screening and health-data management platform, HealthTab™, at select Shoppers Drug Mart locations. Through this pilot program, patients will have greater access to earlier diabetes detection […]
Avricore Health’s HealthTab™ Signs Distribution Agreement To Expand Pharmacy Network and Test Offering
VANCOUVER, BC – (GLOBE NEWSWIRE) – May 31, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada. This agreement allows the Company to distribute in Canada Abbott’s […]
Avricore Health Announces Return of HealthTab™ Founder to Communications and Marketing Role
The Company welcomes the return of Will Seccombe, co-creator of HealthTab™, as he takes on the Company’s communications strategies to support the next growth phase. VANCOUVER, BC – March 26, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Avricore Health is pleased to announce the return of HealthTab Co-Founder, Will […]
Avricore Health Partners With Avrok Laboratories To Offer Real-Time COVID-19 Screening for Travelers
Utilizing HealthTab™ and rapid-antigen tests at resort locations to screen for the virus prior to return, with validation from Avrok Laboratories, US travellers can return home with peace of mind. VANCOUVER, BC – (GLOBE NEWSWIRE) – February 16, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a Letter […]
Avricore Health Completes $1.54 Million Financing
VANCOUVER, BRITISH COLUMBIA – February 9, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has closed its non-brokered private placement announced on February 3rd for gross proceeds of $1,540,000. The Company will issue 7,000,000 units at $0.22 per unit and will pay finders fees totaling $56,320 and issue 256,000 finders […]
